Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver Cirrhosis”

2,643 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,643 results

Large-scale testing (Phase 3)Looking for participantsNCT06051617
What this trial is testing

Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis

Who this might be right for
Primary Biliary Cholangitis
Gilead Sciences 318
Not applicableUnknownNCT03337074
What this trial is testing

Paternally Inherited Phenotypes in Cholestasis

Who this might be right for
CholestasisPrimary Sclerosing CholangitisPrimary Biliary Cirrhosis
Guy's and St Thomas' NHS Foundation Trust 200
Early research (Phase 1)Study completedNCT01359462
What this trial is testing

Multiple-dose Pharmacokinetics Study of Tolvaptan Tablets in Chinese Patients With Hepatocirrhosis

Who this might be right for
Hepatic CirrhosisAscites
Otsuka Beijing Research Institute 11
Not applicableUnknownNCT06114355
What this trial is testing

Comparison of Pre-operative EUS Guided and Intra-operative Direct Portal Vein Pressure Measurement in Pretransplant Cirrhotics

Who this might be right for
Liver Cirrhosis
Asian Institute of Gastroenterology, India 25
Post-approval studies (Phase 4)Study completedNCT05724485
What this trial is testing

Effect of Branched-chain Amino Acids (BCAA) to Muscle Cramps in Patients With Cirrhosis

Who this might be right for
Muscle CrampCirrhosisQuality of Life
Mahidol University 48
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07128290
What this trial is testing

PErioperative CISGEM + Rilvegostomig in High-Risk Resectable Intra Hepatic CholangioCarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
Federation Francophone de Cancerologie Digestive 49
Not applicableUnknownNCT03731923
What this trial is testing

Abbreviated MRI for HCC Surveillance

Who this might be right for
Hepatocellular CarcinomaLiver CirrhosisChronic Hepatitis
Seoul National University Hospital 257
Not applicableStudy completedNCT01524562
What this trial is testing

HIV Accelerated Liver Disease in Uganda

Who this might be right for
Fibrosis
National Institute of Allergy and Infectious Diseases (NIAID) 786
Not applicableNot Yet RecruitingNCT07470515
What this trial is testing

Fiber-Optic Navigation During TIPS Creation: A Prospective Pilot Study

Who this might be right for
Liver CirrhosisRefractory AscitesVariceal Bleeding+1 more
Medical University Innsbruck 30
Not applicableStudy completedNCT04058327
What this trial is testing

MHE in Patients With Liver Diseases

Who this might be right for
Hepatic EncephalopathyMinimal Hepatic EncephalopathyOvert Hepatic Encephalopathy
Qin Ning 252
Not applicableEnrolling By InvitationNCT05433948
What this trial is testing

Diagnosing Minimal Hepatic Encephalopathy

Who this might be right for
Hepatic EncephalopathyLiver Cirrhosis
Esbjerg Hospital - University Hospital of Southern Denmark 550
Post-approval studies (Phase 4)UnknownNCT06371196
What this trial is testing

Clinical Study on the Treatment of Elevated Total Bilirubin in Primary Biliary Cholangitis With Baobao Dan Capsule

Who this might be right for
Primary Biliary Cholangitis
Mei Han 60
Not applicableStudy completedNCT02389127
What this trial is testing

Relationship Between HbA1c and Chronic Glycemia in Patients With Cirrhosis

Who this might be right for
CirrhosisDiabetes Mellitus, Type 2
University of Arkansas 50
Large-scale testing (Phase 3)Active Not RecruitingNCT06383403
What this trial is testing

Elafibranor in Adults With Primary Biliary Cholangitis and Inadequate Response or Intolerance to Ursodeoxycholic Acid.

Who this might be right for
Primary Biliary Cholangitis
Ipsen 69
Testing effectiveness (Phase 2)Study completedNCT00856869
What this trial is testing

Clearance of NRL972 in Patients With Cirrhosis, Nonalcoholic Steatohepatitis (NASH) and in Healthy Volunteers

Who this might be right for
Hepatic CirrhosisNonalcoholic Steatohepatitis
Norgine 52
Early research (Phase 1)Study completedNCT01289951
What this trial is testing

Pharmacokinetic Study of Raltegravir in Human Immunodeficiency Virus/Hepatitis C Virus (HIV/VHC) Coinfected Patients With Advanced (Child-Pugh C) Hepatic Cirrhosis

Who this might be right for
Human Immunodeficiency VirusHepatitis C
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 10
Large-scale testing (Phase 3)Study completedNCT00370253
What this trial is testing

Noradrenalin vs Terlipressin in Hepatorenal Syndrome

Who this might be right for
Hepatorenal Syndrome
University of Turin, Italy 20
Not applicableLooking for participantsNCT06794853
What this trial is testing

Mechanism of TIPS to Improve Sarcopenia

Who this might be right for
SarcopeniaMechanismCirrhosis
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 132
Not applicableStudy completedNCT01695083
What this trial is testing

Non Invasive Measurements of Fibrosis, Inflammation and Steatohepatitis in Morbidly Obese Patients

Who this might be right for
Morbid ObesityNon Alcoholic Steatohepatitis
Assistance Publique - Hôpitaux de Paris 186
Large-scale testing (Phase 3)Study completedNCT02319031
What this trial is testing

Safety and Efficacy Study of the Combination Daclatasvir (60 mg), Sofosbuvir (400 mg) and Ribavirin (Weight-based Dosing) for 12 or 16 Weeks in Subjects With Genotype 3 Chronic HCV Infection With or Without Prior Treatment Experience and Advanced Fibrosis or Compensated Cirrhosis

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 53
Load More Results